Latest Updates

Study

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

September 30, 2019

Share this article
Study

Latest Updates

News

Press Release

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View Article
Journal

Could Aiming Insulin at the Liver Be an Answer to Using Less?

View Article
Interview

Bruce Bode, MD: Hypoglycemic Effect of Hepatic-Directed Insulin

View Article
View All